Actinic Keratoses Treatment With Metvix® in Combination With Light

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Limoges
• Collaborators: Galderma; Galderma R&D
• Treatments: Methyl 5-aminolevulinate

Criteria

Inclusion Criteria:

• Male or female above 18 years;

• Subject with clinical diagnosis of mild Actinic Keratosis (AK) on the face or the scalp with or without clinical diagnosis of moderate AK on the target areas (TAs);

Exclusion Criteria:

• Subject with clinical diagnosis of at least one severe AK on TAs

• Subject with clinical diagnosis of other skin disease (including non-melanoma skin cancer) on the TAs;

• Subject with pigmented AK on the TAs